Article Information
History
- May 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Maitreyi Sahu1,*,**,
- Cara J. Bayer2,*,
- D. Allen Roberts3,
- Heidi van Rooyen4,
- Alastair van Heerden5,6,
- Maryam Shahmanesh7,
- Stephen Asiimwe8,
- Kombi Sausi4,
- Nsika Sithole7,
- Roger Ying9,
- Darcy W. Rao2,3,
- Meighan L. Krows2,
- Adrienne E. Shapiro2,10,
- Jared M. Baeten2,3,10,11,
- Connie Celum2,3,10,
- Paul Revill12,
- Ruanne V. Barnabas13,14,
- for the Delivery Optimization of Antiretroviral Therapy (DO ART) Study Team
- 1Department of Health Metrics Sciences, University of Washington, Seattle, WA, USA
- 2Department of Global Health, University of Washington, Seattle, WA, USA
- 3Department of Epidemiology, University of Washington, Seattle, WA, USA
- 4Human Sciences Research Council, Western Cape, South Africa
- 5SAMRC/WITS Developmental Pathways for Health Research Unit, Department of Paediatrics, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa
- 6Center for Community Based Research, Human Sciences Research Council, KwaZulu-Natal, South Africa
- 7Africa Health Research Institute, KwaZulu-Natal, South Africa
- 8Integrated Community-Based Initiatives, Kabwohe, Uganda
- 9School of Medicine, Yale University, New Haven, CT, USA
- 10Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA
- 11Gilead Sciences, Foster City, CA, USA
- 12University of York, York, UK
- 13Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
- 14Harvard Medical School, Boston, MA, USA
- ↵** Corresponding author; email: msahu{at}uw.edu
↵* Authors contributed equally.